Pharmacology of a new centrally acting muscle relaxant (RJ-64).
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology; D002415:Cats; D002753:Chlorzoxazone / Q000494:pharmacology; D007395:Interneurons / Q000187:drug effects; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D009119:Muscle Contraction / Q000187:drug effects; D009125:Muscle Relaxants, Central / Q000008:administration & dosage / Q000494:pharmacology*; D009132:Muscles / Q000187:drug effects; D009538:Nicotine / Q000037:antagonists & inhibitors; D010069:Oxadiazoles / Q000494:pharmacology*; D051381:Rats; D012018:Reflex / Q000187:drug effects; D013035:Spasm / Q000139:chemically induced; D013331:Strychnine; D009435:Synaptic Transmission / Q000187:drug effects
D000927:Anticonvulsants; D009125:Muscle Relaxants, Central; D010069:Oxadiazoles; D009538:Nicotine; D002753:Chlorzoxazone; D013331:Strychnine